Cochrane Abstracts
Finasteride for benign prostatic hyperplasia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Finasteride for Benign Prostatic Hyperplasia." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439599/all/Finasteride_for_benign_prostatic_hyperplasia.
Finasteride for benign prostatic hyperplasia. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439599/all/Finasteride_for_benign_prostatic_hyperplasia. Accessed November 22, 2024.
Finasteride for benign prostatic hyperplasia. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439599/all/Finasteride_for_benign_prostatic_hyperplasia
Finasteride for Benign Prostatic Hyperplasia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439599/all/Finasteride_for_benign_prostatic_hyperplasia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Finasteride for benign prostatic hyperplasia
ID - 439599
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439599/all/Finasteride_for_benign_prostatic_hyperplasia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
